JP2013522372A5 - - Google Patents

Download PDF

Info

Publication number
JP2013522372A5
JP2013522372A5 JP2013501427A JP2013501427A JP2013522372A5 JP 2013522372 A5 JP2013522372 A5 JP 2013522372A5 JP 2013501427 A JP2013501427 A JP 2013501427A JP 2013501427 A JP2013501427 A JP 2013501427A JP 2013522372 A5 JP2013522372 A5 JP 2013522372A5
Authority
JP
Japan
Prior art keywords
phenylethyl
quinolinecarboxamide
phenyl
trifluoromethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013501427A
Other languages
English (en)
Japanese (ja)
Other versions
JP5819397B2 (ja
JP2013522372A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/029579 external-priority patent/WO2011119701A1/en
Publication of JP2013522372A publication Critical patent/JP2013522372A/ja
Publication of JP2013522372A5 publication Critical patent/JP2013522372A5/ja
Application granted granted Critical
Publication of JP5819397B2 publication Critical patent/JP5819397B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013501427A 2010-03-23 2011-03-23 Trpv4拮抗薬 Expired - Fee Related JP5819397B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31643210P 2010-03-23 2010-03-23
US61/316,432 2010-03-23
PCT/US2011/029579 WO2011119701A1 (en) 2010-03-23 2011-03-23 Trpv4 antagonists

Publications (3)

Publication Number Publication Date
JP2013522372A JP2013522372A (ja) 2013-06-13
JP2013522372A5 true JP2013522372A5 (cg-RX-API-DMAC7.html) 2014-05-01
JP5819397B2 JP5819397B2 (ja) 2015-11-24

Family

ID=44673594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013501427A Expired - Fee Related JP5819397B2 (ja) 2010-03-23 2011-03-23 Trpv4拮抗薬

Country Status (5)

Country Link
US (1) US8658636B2 (cg-RX-API-DMAC7.html)
EP (1) EP2549872B1 (cg-RX-API-DMAC7.html)
JP (1) JP5819397B2 (cg-RX-API-DMAC7.html)
ES (1) ES2561674T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011119701A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2832731A4 (en) 2012-03-27 2015-08-19 Shionogi & Co AROMATIC HETEROCYCLIC CHAIN 5-CORE DERIVED DERIVATIVE HAVING TRPV4 INHIBITORY ACTIVITY
WO2014089013A1 (en) 2012-12-03 2014-06-12 Indiana University Research And Technology Corporation Use of trpv4 antagonists to ameliorate hydrocephalus and related materials and methods
WO2015046193A1 (ja) 2013-09-25 2015-04-02 塩野義製薬株式会社 Trpv4阻害活性を有する芳香族複素環式アミン誘導体
US11701358B2 (en) 2017-02-24 2023-07-18 Indiana University Research And Technology Corporation Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases
CA3180132A1 (en) 2020-04-30 2021-10-30 Raqualia Pharma Inc. Pyrimidin-4(3h)-one derivatives as trpv4 antagonists
CA3189206A1 (en) 2020-07-16 2022-01-20 Raqualia Pharma Inc. Trpv4 inhibitor as therapeutic agent for ocular disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW531537B (en) * 1995-12-27 2003-05-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
PL347721A1 (en) * 1998-11-20 2002-04-22 Smithkline Beecham Spa Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
SE0004054D0 (sv) 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
GB0028964D0 (en) 2000-11-28 2001-01-10 Smithkline Beecham Spa Novel compounds
CN101360738A (zh) 2005-12-21 2009-02-04 佩因赛普托药物公司 调节门控离子通道的组合物和方法
JP5607046B2 (ja) * 2008-07-25 2014-10-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Trpv4拮抗薬
WO2011119693A1 (en) * 2010-03-23 2011-09-29 Glaxosmithkline Llc Trpv4 antagonists

Similar Documents

Publication Publication Date Title
JP2017510554A5 (cg-RX-API-DMAC7.html)
JP2013522372A5 (cg-RX-API-DMAC7.html)
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
JP2018512381A5 (cg-RX-API-DMAC7.html)
JP6505023B2 (ja) Cnsおよび他の障害を治療するための、pde4アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物
JP2014526549A5 (cg-RX-API-DMAC7.html)
JP2017510555A5 (cg-RX-API-DMAC7.html)
JP2013528204A5 (cg-RX-API-DMAC7.html)
JP2009542638A5 (cg-RX-API-DMAC7.html)
JP2019530695A5 (cg-RX-API-DMAC7.html)
JP2013523889A5 (cg-RX-API-DMAC7.html)
JP2017505794A5 (cg-RX-API-DMAC7.html)
JP2020510015A5 (cg-RX-API-DMAC7.html)
JP2010518026A5 (cg-RX-API-DMAC7.html)
JP2014528433A5 (cg-RX-API-DMAC7.html)
IL279800B1 (en) Selective allosteric inhibitors of epidermal growth factor receptor mutants, pharmaceutical compositions comprising them and use thereof
JP2010510319A5 (cg-RX-API-DMAC7.html)
JP2016538313A5 (cg-RX-API-DMAC7.html)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2009529047A5 (cg-RX-API-DMAC7.html)
SI3018132T1 (en) Condensed imidazole derivatives useful as IDO inhibitors
JP2012503018A5 (cg-RX-API-DMAC7.html)
JP2013523884A5 (cg-RX-API-DMAC7.html)
RU2014120374A (ru) Имидазопиридазины
JP2005538099A5 (cg-RX-API-DMAC7.html)